Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalence study of higher-strength versus multiple lower-strength prolonged-release oxycodone/naloxone tablets in chronic pain
2013-004888-31Phase 3Completed
- Sponsor
- Mundipharma Research
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + naloxone in pain (2 arms), sponsored by Mundipharma Research. Primary endpoints: Equivalence in analgesic efficacy and Equivalence in bowel function. Started Apr 2014; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
pain
Beyond the preview
Go deeper on 2013-004888-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004888-31.